title: Brentuximab vedotin and panobinostat: new drugs for Hodgkin's lymphoma--can they make one of medical oncology's chemotherapy success stories more successful?
authors.forename: George P
authors.initials: GP
authors.lastname: Canellos
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D000079963:Brentuximab Vedotin; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage*; D018796:Immunoconjugates / Q000627:therapeutic use*; D007211:Indoles; D008297:Male; D000077767:Panobinostat
chemical_list: D000970:Antineoplastic Agents; D006877:Hydroxamic Acids; D018796:Immunoconjugates; D007211:Indoles; D000079963:Brentuximab Vedotin; D000077767:Panobinostat